According to FutureWise analysis the market for Interventional Oncology in 2023 was US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%.

Interventional oncology is a specialized field that utilizes image guidance for minimally invasive medical procedures aimed at the diagnosis, palliation, and treatment of various types of cancer. Techniques such as fluoroscopy, ultrasound, and computed tomography are employed to accurately target affected areas, whether for diagnosis or to alleviate pain. These interventions are often combined with other cancer treatments, including chemotherapy, radiation therapy, and surgery.

The benefits of interventional oncology procedures include shorter hospital stays, faster recovery times, enhanced precision in treatment delivery, and reduced side effects, making them an attractive option for patients.

Recent technological advancements, the advantages associated with minimally invasive surgical procedures, and increased government funding have contributed significantly to the growth of this market. The market is diverse, encompassing various product categories such as embolization devices, non-radioactive embolic agents, ablation devices, support devices, and guidewires. Notably, the ablation devices segment is further divided into radiofrequency ablation, microwave ablation, and cryoablation devices.

Among these, the embolization devices segment is expected to experience substantial growth during the forecast period. This is largely due to the numerous benefits associated with embolization, a procedure that blocks blood supply to tumors by introducing emboli into the bloodstream, either through irradiation or chemical methods. This targeted approach has made embolization a preferred treatment choice worldwide.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=2336%20&type=requestsample

 Interventional Oncology Market Segmentation:

By Product

• Embolization Devices
  • Radioembolic Agents
  • Non-Radioactive Embolic Agents
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
• Support Devices
  • Microcatheters
  • Guidewires

 By Procedure

• Thermal Tumour Ablation
• Non-thermal Tumour Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland Embolization

 By Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers

 By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

 Competitive Landscape in Interventional Oncology Market:

• Medtronic
• Boston Scientific
• BTG Plc.
• Terumo
• Merit Medical
• Sirtex
• Ethicon
• Cook Medical
• Teleflex
• HealthTronics
• MedWaves Medical
• IceCure Medical
• Interface Biomaterial BV
• Mermaid Medicals
• ABK Biomedical
• Guerbet
• Endo Shape
• Instylla
• Shape Memory Medical
• Monteris Medical
• Trisalus Lifesciences

Ask For Discount: https://www.futurewiseresearch.com/checkout.aspx?ReportId=2336&license=multi

 **Objectives of this Study: **

1. To provide a comprehensive analysis of the Interventional Oncology Market By Product, By Procedure, By Cancer Type and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com